d-Alanine as a biomarker and a therapeutic option for severe influenza virus infection and COVID-19

Shihoko Kimura-Ohba1,2, Masamitsu N. Asaka3, Daichi Utsumi3, Yoshitsugu Takabatake4, Atsushi Takahashi4, Yasuhiro Yasutomi3, Yoshitaka Isaka4, Tomonori Kimura1,2,4
1Reverse Translational Research Project, Center for Rare Disease Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), 567-0085, Japan
2KAGAMI Project, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), 567-0085, Japan
3Laboratory of Immunoregulation and Vaccine Research, Tsukuba Primate Research Center, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), 305-0843, Japan
4Department of Nephrology, Osaka University Graduate School of Medicine, 565-0871, Japan

Tài liệu tham khảo

Worldometer. [Accessed August 9, 2022] COVID-19 Coronavirus Pandemic. https://wwwworldometersinfo/coronavirus/. Schwartz, 2018, The spanish flu, epidemics, and the turn to biomedical responses, Am. J. Public Health, 108, 1455, 10.2105/AJPH.2018.304581 <collab> Novel Swine-Origin Influenza, 2009, Emergence of a novel swine-origin influenza A (H1N1) virus in humans, N. Engl. J. Med., 360, 2605, 10.1056/NEJMoa0903810 ClinicalTrials.gov. [Accessed August 9, 2022] https://clinicaltrials.gov/ct2/results?cond=covid-19&term=&cntry=&state=&city=&dist=. Fakih, 2022, COVID-19 hospital prevalence as a risk factor for mortality: an observational study of a multistate cohort of 62 hospitals, BMJ Qual. Saf., 31, 45, 10.1136/bmjqs-2021-013721 Çınar, 2021, Investigation of the effect of comorbidity on mortality in patients with COVID-19: a systematic review and meta-analysis, Biointerface Res. Appl. Chem., 12, 5579, 10.33263/BRIAC124.55795590 Hamase, 2002, D-amino acids in mammals and their diagnostic value, J. Chromatogr. B Anal. Technol. Biomed. Life Sci., 781, 73, 10.1016/S1570-0232(02)00690-6 Kimura, 2016, Chiral amino acid metabolomics for novel biomarker screening in the prognosis of chronic kidney disease, Sci. Rep., 6, 26137, 10.1038/srep26137 Hesaka, 2019, D-serine reflects kidney function and diseases, Sci. Rep., 9, 5104, 10.1038/s41598-019-41608-0 Iwata, 2021, Identification of diabetic nephropathy in patients undergoing kidney biopsy through blood and urinary profiles of D-serine, Kidney360, 2, 1734, 10.34067/KID.0004282021 Kawamura, 2022, Measurement of glomerular filtration rate using endogenous d-serine clearance in living kidney transplant donors and recipients, EClinicalMedicine, 43, 10.1016/j.eclinm.2021.101223 Kimura, 2020, D-amino acids and kidney diseases, Clin. Exp. Nephrol., 24, 404, 10.1007/s10157-020-01862-3 Sasabe, 2016, Interplay between microbial d-amino acids and host d-amino acid oxidase modifies murine mucosal defence and gut microbiota, Nat. Microbiol., 1, 16125, 10.1038/nmicrobiol.2016.125 Hesaka, 2021, D-serine mediates cellular proliferation for kidney remodeling, Kidney360, 2, 1611, 10.34067/KID.0000832021 Schell, 1995, D-serine, an endogenous synaptic modulator: localization to astrocytes and glutamate-stimulated release, Proc. Natl. Acad. Sci. U. S. A., 92, 3948, 10.1073/pnas.92.9.3948 Suzuki, 2021, Host-microbe cross-talk governs amino acid chirality to regulate survival and differentiation of B cells, Sci. Adv., 7, 10.1126/sciadv.abd6480 Sasabe, 2018, Emerging role of D-amino acid metabolism in the innate defense, Front. Microbiol., 9, 933, 10.3389/fmicb.2018.00933 Parker, 2020, Sensing living bacteria in vivo using d-alanine-derived (11)C radiotracers, ACS Central Sci., 6, 155, 10.1021/acscentsci.9b00743 Asaka, 2021, Highly susceptible SARS-CoV-2 model in CAG promoter-driven hACE2-transgenic mice, JCI Insight, 6, 10.1172/jci.insight.152529 Kimura-Ohba, 2016, Transient increase of fractional anisotropy in reversible vasogenic edema, J. Cereb. Blood Flow Metab., 36, 1731, 10.1177/0271678X16630556 Miyoshi, 2009, Determination of D-serine and D-alanine in the tissues and physiological fluids of mice with various D-amino-acid oxidase activities using two-dimensional high-performance liquid chromatography with fluorescence detection, J. Chromatogr. B, 877, 2506, 10.1016/j.jchromb.2009.06.028 Hamase, 2010, Simultaneous determination of hydrophilic amino acid enantiomers in mammalian tissues and physiological fluids applying a fully automated micro-two-dimensional high-performance liquid chromatographic concept, J. Chromatogr. A, 1217, 1056, 10.1016/j.chroma.2009.09.002 Hamase, 2018, Determination of trace amounts of chiral amino acids in complicated biological samples using two-dimensional high-performance liquid chromatography with an innovative “shape-fitting” peak identification/quantification method, Chromatography, 39, 147, 10.15583/jpchrom.2018.019 Nassar, 2021, Diabetes mellitus and COVID-19: review article, Diabetes Metab. Syndrome, 15, 10.1016/j.dsx.2021.102268 Nagata, 1987, Free D-amino acids in human plasma in relation to senescence and renal diseases, Clin. Sci. (Lond.), 73, 105, 10.1042/cs0730105 Morikawa, 2008, Circadian changes of D-alanine and related compounds in rats and the effect of restricted feeding on their amounts, J. Chromatogr. B Anal. Technol. Biomed. Life Sci., 875, 168, 10.1016/j.jchromb.2008.04.004 Morikawa, 2017, Sleep-awake profile related circadian D-alanine rhythm in human serum and urine, Chromatography, 38, 53, 10.15583/jpchrom.2017.003 Karakawa, 2013, Two-dimensional high-performance liquid chromatographic determination of day-night variation of D-alanine in mammals and factors controlling the circadian changes, Anal. Bioanal. Chem., 405, 8083, 10.1007/s00216-013-7071-2 Min, 2011, Determination of DL-amino acids, derivatized with R(-)-4-(3-isothiocyanatopyrrolidin-1-yl)-7-(N, N-dimethylaminosulfonyl)-2,1,3-benz oxadiazole, in nail of diabetic patients by UPLC-ESI-TOF-MS, J. Chromatogr. B Anal. Technol. Biomed. Life Sci., 879, 3220, 10.1016/j.jchromb.2011.02.016 Ganote, 1974, The nature of D-serine–induced nephrotoxicity, Am. J. Pathol., 77, 269